As of 2025-11-07, the Relative Valuation of SAGE Therapeutics Inc (SAGE) is (108.67) USD. This relative valuation is based on P/E multiples. With the latest stock price at 8.68 USD, the upside of SAGE Therapeutics Inc based on Relative Valuation is -1351.9%.
The range of the Relative Valuation is (91.54) - (113.42) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.5x - 23.6x | 20.6x |
| Forward P/E multiples | 19.1x - 30.4x | 24.8x |
| Fair Price | (91.54) - (113.42) | (108.67) |
| Upside | -1154.6% - -1406.6% | -1351.9% |
| Date | P/E |